Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 24143922)

1.

Gap junction blockers: a potential approach to attenuate morphine withdrawal symptoms.

Moradi S, Charkhpour M, Ghavimi H, Motahari R, Ghaderi M, Hassanzadeh K.

J Biomed Sci. 2013 Oct 21;20:77. doi: 10.1186/1423-0127-20-77.

2.

Repeated central administration of selegiline attenuated morphine physical dependence in rat.

Parvizpour A, Charkhpour M, Habibi-asl B, Shakhsi M, Ghaderi M, Hassanzadeh K.

Pharmacol Rep. 2013;65(3):593-9.

3.

Duloxetine attenuated morphine withdrawal syndrome in the rat.

Charkhpour M, Jafari RM, Ghavimi H, Ghanbarzadeh S, Parvizpur A.

Drug Res (Stuttg). 2014 Aug;64(8):393-8. doi: 10.1055/s-0033-1358728. Epub 2013 Nov 21.

PMID:
24265113
4.

Phenothiazine-type antipsychotics may attenuate naloxone-precipitated withdrawal jumping in morphine-dependent mice.

Wu SZ, Chen KT, Chen JY, Sung KC, Wang JJ, Liu KS, Chu CC.

Acta Anaesthesiol Taiwan. 2012 Dec;50(4):167-71. doi: 10.1016/j.aat.2012.12.007. Epub 2013 Jan 11.

PMID:
23385039
5.

Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms.

Shahidi S, Hasanein P.

Brain Res Bull. 2011 Aug 10;86(1-2):118-22. doi: 10.1016/j.brainresbull.2011.06.019. Epub 2011 Jul 7.

PMID:
21763761
6.

Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".

Fdez Espejo E, Cador M, Stinus L.

Psychopharmacology (Berl). 1995 Nov;122(2):122-30.

PMID:
8848527
7.

Naloxone-precipitated withdrawal as a function of the morphine-naloxone interval.

Linseman MA.

Psychopharmacology (Berl). 1977 Oct 20;54(2):159-64.

PMID:
412210
8.
9.

Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.

Azizi H, Mirnajafi-Zadeh J, Rohampour K, Semnanian S.

Neurosci Lett. 2010 Oct 4;482(3):255-9. doi: 10.1016/j.neulet.2010.07.050. Epub 2010 Aug 2.

PMID:
20667500
10.

An-jun-ning, a traditional herbal formula, attenuates spontaneous withdrawal symptoms via modulation of the dopamine system in morphine-dependent rats.

Gao JL, Tu SA, Liu J, Zhang JM, Huang Y, Han M, Liang JH.

BMC Complement Altern Med. 2014 Aug 19;14:308. doi: 10.1186/1472-6882-14-308.

11.

Acute administration of pioglitazone attenuates morphine withdrawal syndrome in rat: a novel role of pioglitazone.

Ghavimi H, Azarfardian A, Maleki-Dizaji N, Hassanzadeh K, Ghanbarzadeh S, Charkhpour M.

Drug Res (Stuttg). 2015 Mar;65(3):113-8. doi: 10.1055/s-0033-1364035. Epub 2014 Feb 6.

PMID:
24504689
12.

On the mechanism(s) of cholecystokinin (CCK): receptor stimulation attenuates morphine dependence in mice.

Rezayat M, Azizi N, Zarrindast MR.

Pharmacol Toxicol. 1997 Sep;81(3):124-9.

PMID:
9335069
13.

Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.

Aricioglu-Kartal F, Kayir H, Tayfun Uzbay I.

Life Sci. 2003 Sep 19;73(18):2363-71.

PMID:
12941438
14.

The inhibitory effect of Hypericum perforatum extract on morphine withdrawal syndrome in rat and comparison with clonidine.

Feily A, Abbasi N.

Phytother Res. 2009 Nov;23(11):1549-52. doi: 10.1002/ptr.2807.

PMID:
19370548
15.

Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.

Schulteis G, Morse AC, Liu J.

Psychopharmacology (Berl). 2004 Oct;175(4):463-72.

PMID:
15083263
16.

Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuate opioid withdrawal in vivo and in vitro.

Rehni AK, Singh N.

Psychopharmacology (Berl). 2012 Mar;220(2):427-38. doi: 10.1007/s00213-011-2489-8. Epub 2011 Sep 20.

PMID:
21931991
17.

Effects of tizanidine administration on precipitated opioid withdrawal signs in rats.

Pinelli A, Trivulzio S, Spezia R.

Drug Alcohol Depend. 1998 Mar 1;50(1):81-8.

PMID:
9589275
18.

Pharmacological modulation of geranylgeranyltransferase and farnesyltransferase attenuates opioid withdrawal in vivo and in vitro.

Rehni AK, Singh TG.

Neuropharmacology. 2013 Aug;71:19-26. doi: 10.1016/j.neuropharm.2013.01.022. Epub 2013 Feb 13.

PMID:
23415632
19.

A dose-response study on the efficacy of tricyclic antidepressants on reducing morphine-withdrawal symptoms.

Liu KS, Chen SJ, Chen YW, Sung KC, Wang JJ.

Acta Anaesthesiol Taiwan. 2013 Mar;51(1):18-21. doi: 10.1016/j.aat.2013.03.002. Epub 2013 May 4.

PMID:
23711601
20.

Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.

Nemoto W, Sato T, Nakagawasai O, Yaoita F, Silberring J, Tadano T, Tan-No K.

Neuropeptides. 2013 Jun;47(3):187-91. doi: 10.1016/j.npep.2012.11.002. Epub 2013 Jan 3.

PMID:
23290539
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk